Skip to Main Content

Paper Details

<i>PTEN</i> Loss and <i>BRCA1</i> Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer.
JCO Precis Oncol
4
2022
Author NameAffiliation
Adam A KrayaPerelman School of Medicine at the University of Pennsylvania
Adam A KrayaPerelman School of Medicine at the University of Pennsylvania
Susan M DomchekPerelman School of Medicine at the University of Pennsylvania
Susan M DomchekBasser Center for BRCA and Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
Katherine L NathansonPerelman School of Medicine at the University of Pennsylvania
Katherine L NathansonBasser Center for BRCA and Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
  • 1 - 6

Datasets

Release 1.2